The Roman Empire strikes back: Abramovich to swap Chelsea for Goztepe

James Shearman
James Shearman
  • 23 Mar 2022 18:11 GMT
  • 3 min read
Roman Abramovich, Chelsea, 2021/22
© ProShots

Chelsea owner Roman Abramovich is reportedly in talks to purchase Turkish Super Lig club Goztepe.

The billionaire is currently in the process of selling the Blues, but is already said to be exploring another European football venture.

Article continues under the video

Abramovich wasn't planning on leaving Chelsea anytime soon, but put the club up for sale at the start of March as a result of pressure coming from his links to Russian president Vladimir Putin.

And, on March 12, Abramovich was disqualified as Chelsea director after the UK government decided to impose sanctions on him and freeze his assets.

''Following the sanctions by the UK government, the Premier League board has disqualified Roman Abramovich as a director of Chelsea Football Club,'' read the Premier League statement.

''The board's decision does not impact on the club's ability to train and play its fixtures.''

Abramovich to buy Goztepe?

Clearly, Abramovich isn't done with making an impact on European football, with his sights set on owning another club in the near future.

According to Turkish newspaper Fanatik, Abramovich's representatives are in talks with Mehmet Sepil, the owner of Goztepe, over a potential takeover.

Fanatik claim that negotiations will continue over the coming days as both parties look to reach an agreement on the terms of the sale.

The news comes after Sepil announced that he would be exiting the Super Lig side at the end of the current campaign.

Whether Abramovich would spend as excessively as he did at Chelsea remains unknown but, if his desire to win is similar to what it was, Goztepe fans can expect to enjoy silverware.

However, the Izmir-based club's supporters may not take kindly to the Russian, for the same reasons that he is no longer in charge of Chelsea.

Never miss the next big transfer!

Get the latest transfer insights and analyses directly in your mailbox.